
RegASK, a leading agentic AI platform for regulatory intelligence and workflow orchestration, has appointed Deanna Coscia as Senior Vice President, Commercial. With over 15 years of experience in life sciences and SaaS, Coscia will spearhead RegASK’s global commercial strategy, focusing on market expansion and platform adoption.
RegASK names Deanna Coscia as SVP, Commercial to lead global strategy.
Coscia brings 15+ years of experience in life sciences and SaaS sales.
Her leadership will drive adoption of RegASK’s AI regulatory platform.
Focus on expanding presence in US and European markets.
Coscia scaled Medable to $500M+ funding with 80% revenue growth in 2024.
RegASK’s AI solutions streamline compliance for regulatory teams.
Deanna Coscia’s appointment strengthens RegASK’s commitment to global growth. Based in the US, she will focus on deepening market penetration in the US and Europe, enabling regulatory teams to adopt RegASK’s AI-driven platform. The platform empowers organizations in consumer products and life sciences to navigate complex compliance landscapes efficiently.
“Deanna brings an exceptional track record of scaling commercial organizations, cultivating trusted client relationships, and delivering strong revenue performance,” said Caroline Shleifer, Founder and CEO of RegASK. “Her leadership will be key as we expand further globally and empower regulatory teams to navigate an increasingly complex and fast-moving compliance environment with confidence.” Coscia’s expertise will accelerate RegASK’s mission to redefine regulatory intelligence.
“I’m excited to join RegASK at this defining stage of its journey,” said Coscia. “The company has achieved its product-market fit, demand is accelerating, and adoption is strong. Together, these factors uniquely position RegASK to redefine how organizations approach regulatory intelligence.” With prior success at Medable, where she drove 80% revenue growth in 2024, Coscia is poised to build a robust commercial engine for RegASK.
Coscia’s 15-year career includes leadership roles at Medable, IBM, and SevOne. At Medable, she scaled the health-tech unicorn to a $2.1B valuation, leading enterprise negotiations with top biopharma clients. Her experience in building high-performing teams and driving market expansion positions her to enhance RegASK’s global footprint and adoption of its agentic AI solutions.
RegASK’s appointment of Deanna Coscia marks a pivotal step in its global expansion. By leveraging her expertise, the company aims to empower regulatory teams worldwide with proactive, AI-driven solutions for compliance and market access.
RegASK is a leading agentic AI regulatory intelligence and workflow orchestration platform that empowers global organizations in highly regulated sectors, including consumer products and life sciences, to proactively navigate complex regulatory landscapes. By combining advanced Agentic AI with experts in the loop, RegASK delivers real-time, actionable insights and end-to-end automation, streamlining compliance processes, mitigating risks, and accelerating market access across more than 140 countries.